Effects of selenium and vitamin E on muscular strength and blood parameters in Steinert disease
Tóm tắt
Six patients with Steinert disease were treated with selenium and vitamin E, for a 24 month period, including a first phase of 12 months, 6 months wash-out interval and a second treatment phase of 6 months. Mean segmental strength values showed significant improvement during the first 12 months of therapy, while marked reductions of serum enzymes CPK, SGOT, SGPT and γ-GT were observed in some patients. The results support the hypothesis that selenium may play a role in the development of muscle damage in Steinert disease.
Tài liệu tham khảo
Alevizos B., Spengos M., Vassilopoulos D., Stefanis C.:γ glutamyl transpeptidase: elevated activity in myotonic dystrophy. J. Neurol. Sci. 28:225–231, 1976.
Blackmore D.J., Stanier P.:Methods for the measurement of trace elements in equine blood by electrothermal atomic absorption spectrophotometry. Atomic spectroscopy 5:215, 1984.
Brooke M.H., Griggs R.C., Mendell J.R., Fenichel G.M., Shumate J.B., Pellegrino R.J.:Clinical trial in Duchenne dystrophy. I: the design of the protocol. Muscle Nerve 4:186–197, 1981.
Bryant S.H.:The physiological basis of myotonia. In: Rowland L.P. (Ed.), Pathogenesis of human muscular dystrophies. Amsterdam-Oxford, Excerpta Medica, 715–728, 1977.
Diplock A.T.:Metabolic functional defects in selenium deficiency. Philos. Trans. R. Soc. Lond. B. 294:105–117, 1981.
Edwards R.H.T., McDonnel M.:Hand-held dynamometer for evaluating voluntary muscle function. Lancet 2:757, 1974.
Fleming C.R., Lie J.Y., McCall J.T. et al.:Selenium deficiency and fatal cardiomyopathy in a patient on home parenteral nutrition. Gastroenterol. 83:689–693, 1982.
Gamstorp I., Gustavson K.H., Hellstrom O., Nordgren B.:A trial of selenium and vitamin E in boys with muscular dystrophy.J. Child Neurol. 1/3:211–214, 1986.
Johnson R.A., Baker S.S., Fallon J.T. et al.:An accidental case of cardiomyopathy and selenium deficiency. N. Engl. J. Med. 304:1210–1212, 1981.
Keshan Disease Research Group.Observations on effect of sodium selenite in prevention of Keshan disease. Clin. Med. J. 92:471–476, 1979.
Mansell P.I., Rawlings J., Allison S.P.:Reversal of a skeletal myopathy with selenium supplementation in a patient on home parenteral nutrition. Clin. Nutr. 6/3:179–183, 1987.
Orndahl G., Rindby A., Sein E.:Myotonic dystrophy and selenium. Acta Med. Scand. 211:493–499, 1982.
Orndahl G., Sellden U., Hallin S., Wetterqvist H., Rindby A., Selen E.:Myotonic dystrophy treated with selenium and vitamin E. Acta Med. Scand. 219:407–414, 1986.
Rossi B., Tonelli S., Bargagna P., Siciliano G.:Livelli sierici di selenio nella distrofia miotonica di Steinert. Atti XXIV Congr. Naz. S.I.N., abstract 201, Pisa 10-12 ottobre, 1984.
Rotruck J.T., Pope A.L., Ganther H.E., Swanson A.B., Hafeman D.G., Hoekstra W.G.:Selenium: biochemical role as a component of glutathione peroxidase. Science 179:585–590, 1973.
Schwarz K.:Development and status of experimental work on factor 3-selenium. Fed. Proc. 20:666–669, 1961.
Spiegel M.R.:Statistica. New York, McGraw-Hill, 1976.
Van Ru A.M., Thomson C.D., MCKenzie J.M., Robinson M.F.:Selenium deficiency in total parenteral nutrition. Am. J. Clin. Nutr. 32:2076–2085, 1979.
Witting L.A.:Vitamin E and lipid antioxidants in free-radical-initiated reactions. In: Prior W.A. (Ed.), Free radicals in biology. New York, Academic Press, 295–319, 1980.